B0CC88 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase MolNFT, Molecular NFT on GenesisL1

4-diphosphocytidyl-2-C-methyl-D-erythritol kinase

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD

IPFS of NFT metadata:

bafybeibsvfw3yvjeri7epqg4wtdej35plogzaai44a5lxpdqerwdyrtqky/metadata.json

IPFS of structure file:

bafybeifnxlzlrmok4jskylh3r2jxacosidieadzgozi4nmrwaxt2nfrnc4/AF-B0CC88-F1-model_v2.pdb

First NFT owner address (eip-55):

0x1B6204b594D54D3E83B7C102EA0B596aAf1188e4

First NFT owner address (bech32):

genesis1rd3qfdv564xnaqahcypw5z6ed2h3rz8ykvjjg4

Current NFT ID #193287 owner (web3):

0x1B6204b594D54D3E83B7C102EA0B596aAf1188e4

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
193287
Accession (UniProt):
B0CC88
Name::
4-diphosphocytidyl-2-C-methyl-D-erythritol kinase
Experimental Method:
Predicted structure
Sequence source:
Acaryochloris marina (strain MBIC 11017)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B0CC88 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B0CC88|ISPE_ACAM1 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase OS=Acaryochloris marina (strain MBIC 11017) OX=329726 GN=ispE PE=3 SV=1 MHAYTLKAPAKINLLLEIIGDRPDGFHELVMVMQSVNLADIVELQPLSGDRIELFCNHPQVPCDQSNLAHRAARLMQEQFPGKGGVAITIDKKIPIGAGLAGGSADAAAVLVGLDLMWGLGLTQAELHTYAAKLGSDIPFCVSGGTALALGRGEELTPLPDLDQLYAVLAKYRSLSVATPWAYKTYRQQFSESYARDPEALEKRRREGHSVELLAAISHRDSQKVPQYLYNDLEKVVLPEHPQVQEIRDLFQSFGALGTMMSGSGPTVFGLADSRSKAELMATQLQTALPDPDLEILVTKFCSSGIQLLS

B0CC88 AF NFT

MOLNFT AF v1

NFT data

MOLNFT B0CC88 research and analysis (ICN3D with VR)

FASTA sequences

We use cookies on this site to enhance your user experience